What is MBS Imaging?
MBS Imaging operates at the intersection of mobile healthcare and specialized diagnostics, focusing primarily on dysphagia management. The company provides essential Modified Barium Swallow Studies (MBSS) and therapeutic interventions for patients suffering from complex voice and swallowing disorders. By deploying advanced diagnostic technology directly to healthcare facilities throughout Northeastern Illinois, the firm eliminates the logistical barriers typically associated with traditional clinical evaluations.
The company's business model is built on the premise of convenience and cost-efficiency, offering immediate access to critical diagnostic data that informs rapid treatment planning. This approach not only improves patient outcomes but also provides a streamlined, high-value service for healthcare providers who require timely, accurate assessments. As a leader in mobile diagnostic solutions, MBS Imaging is effectively addressing a significant gap in the continuum of care for patients with swallowing impairments.
How much funding has MBS Imaging raised?
MBS Imaging has raised a total of $52K across 1 funding round:
Debt
$52K
Debt (2021): $52K with participation from PPP
Key Investors in MBS Imaging
PPP
Public-Private Partnership
What's next for MBS Imaging?
With the recent infusion of capital, MBS Imaging is poised to execute a strategic expansion plan aimed at broadening its service reach and deepening its clinical capabilities. The company is expected to prioritize the acquisition of next-generation endoscopic equipment and the expansion of its clinical workforce to meet the rising demand for mobile diagnostic services. Furthermore, the firm will likely focus on optimizing its operational logistics to improve service delivery times across its existing and future service territories.
Looking ahead, the company's growth strategy will likely involve leveraging its established reputation in Northeastern Illinois to explore potential partnerships with larger healthcare networks. By maintaining a focus on high-quality, patient-centric care, MBS Imaging is well-positioned to solidify its market share and potentially explore new geographic markets, thereby reinforcing its status as a critical partner in the dysphagia diagnostic ecosystem.
